Guggenheim Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $177K | Sell |
|
|||||
|
2024
Q3 | $306K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $884K | Sell |
|
|||||
|
2022
Q2 | $478K | Sell |
|
|||||
|
2022
Q1 | $718K | Buy |
|
|||||
|
2021
Q4 | $583K | Buy |
|
|||||
|
2021
Q3 | $992K | Sell |
|
|||||
|
2021
Q2 | $1.08M | Buy |
|
|||||
|
2021
Q1 | $972K | Buy |
|
|||||
|
2020
Q4 | $515K | Buy |
|